Tiny tablets could make PKU management easier for patients

NCT ID NCT07671859

Not yet recruiting Disease control Sponsor: Nutricia UK Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new microtablet protein substitute for people with phenylketonuria (PKU), a condition requiring a strict low-protein diet. The microtablets combine protein with vitamins and minerals, aiming to be easier to take than current liquid or powder options. About 20 adults and children (ages 4+) will try the tablets for 28 days, and researchers will check how well they tolerate and accept them.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: amino acid based microtablet protein substitute with vitamins and minerals
What this could lead to: If successful, this could offer a more convenient and acceptable way for people with PKU to manage their condition, potentially improving daily compliance.
What could go wrong: This is a very small, early case series (20 people) lasting only 29 days, so results may not apply to everyone. It focuses on tolerance and acceptability, not long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA (PKU) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

phenylketonuria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PHENYLKETONURIA (PKU)

Contacts and locations

Locations

University Hospitals Bristol and Weston NHS Foundation Trust

Bristol, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.